Malgorzata Giel-Pietraszuk

Title: Malgorzata Giel-Pietraszuk: Innovator in DNA Methylation Research

Introduction

Malgorzata Giel-Pietraszuk is a prominent inventor based in Poznan, Poland. She has made significant contributions to the field of biochemistry, particularly in the area of DNA methylation. Her innovative work has the potential to impact the treatment of various diseases associated with abnormal DNA methylation.

Latest Patents

Malgorzata holds a patent for a cytosine analogue, which includes a method of preparation for this analogue, a DNA methyltransferase 1 inhibitor, and a method for inhibiting DNA methylation. This invention is aimed at treating diseases linked to deviations from normal DNA methylation. The cytosine analogue may consist of 1, N, 5 and 6-substituted derivatives of cytosine or 5,6-dihydrocytosine. The chemical formula of the analogue includes various substituents, which can be alkyl, aryl, hydroxyalkyl, aminoalkyl, and more.

Career Highlights

Malgorzata is affiliated with the Institute of Bioorganic Chemistry, where she conducts her research. Her work has garnered attention for its innovative approach to addressing complex biological issues. She has successfully developed a method that could lead to new therapeutic strategies for diseases related to DNA methylation.

Collaborations

Malgorzata has collaborated with notable colleagues such as Jan Barciszewski and Wojciech T. Markiewicz. These partnerships have enriched her research and contributed to the advancement of knowledge in her field.

Conclusion

Malgorzata Giel-Pietraszuk is a trailblazer in the realm of DNA methylation research, with her patented innovations paving the way for future medical advancements. Her contributions are vital in the ongoing quest to understand and treat diseases linked to DNA methylation abnormalities.